These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37474299)

  • 1. Exploring the role of m6A modification in the great obstetrical syndromes.
    Ning J; Yan J; Yang H
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2234541. PubMed ID: 37474299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research progress on N6-methyladenosine in the human placenta.
    Zhou W; Xue P; Yang Y; Xia L; Yu B
    J Perinat Med; 2022 Oct; 50(8):1115-1123. PubMed ID: 35606944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine (m6A) Modification in Preeclampsia.
    Zhang T; Jiang Z; Yang N; Ge Z; Zuo Q; Huang S; Sun L
    Reprod Sci; 2023 Nov; 30(11):3144-3152. PubMed ID: 37286755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine dynamics in placental development and trophoblast functions, and its potential role in placental diseases.
    Wu S; Liu K; Cui Y; Zhou B; Zhao H; Xiao X; Zhou Q; Ma D; Li X
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167290. PubMed ID: 38866113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion.
    Zhang Y; Yang H; Long Y; Zhang Y; Chen R; Shi J; Chen J
    Sci Rep; 2021 Dec; 11(1):24357. PubMed ID: 34934095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N6-Methyladenosine Regulator
    Zhao Y; Sun J; Jin L
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.
    Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C
    FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTO protein regulates the TGF-β signalling pathway through RNA N6-methyladenosine modification to induce unexplained recurrent spontaneous abortion.
    Zhang J; Liu X; Gao Y
    FEBS J; 2024 Apr; 291(7):1545-1559. PubMed ID: 38245815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases.
    Zhang B; Jiang H; Dong Z; Sun A; Ge J
    Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of N6-methyladenosine (m6A) in eye diseases.
    Gao JF; Zhang L
    Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of METTL3 expression and m6A RNA methylation in placental trophoblasts in preeclampsia.
    Gu Y; Chu X; Morgan JA; Lewis DF; Wang Y
    Placenta; 2021 Jan; 103():43-49. PubMed ID: 33070036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
    Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
    Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.
    Xu Z; Lv B; Qin Y; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
    Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
    Front Oncol; 2022; 12():927640. PubMed ID: 35936737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
    Fang X; Li M; Yu T; Liu G; Wang J
    Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
    Fang F; Wang X; Li Z; Ni K; Xiong C
    Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulatory mechanisms of N6-methyladenosine modification in ferroptosis and its implications in disease pathogenesis.
    Tao X; Kang N; Zheng Z; Zhu Z; Ma J; He W
    Life Sci; 2024 Oct; 355():123011. PubMed ID: 39181316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.
    He C; Teng X; Wang L; Ni M; Zhu L; Liu J; Lv W; Hu J
    Mol Biol Rep; 2023 Oct; 50(10):8691-8703. PubMed ID: 37598390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.